Ensign Group vs Vaxcyte
Ensign Group (ENSG), health care, and Vaxcyte (PCVX), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Ensign Group is worth $10.9B on the stock market and Vaxcyte $9.4B: Ensign Group is valued at 15% more. Over the past year Ensign Group's share price has moved +5.45% and Vaxcyte's +24.4%.
Key facts
- Ensign Group market value
- $10.9B
- Vaxcyte market value
- $9.4B
- Ensign Group P/E
- 27.7
- Ensign Group revenue
- $5.1BFY to 2025-12-31
- Superinvestors holding both
- 0
Market values as of .
| Measure | Ensign Group | Vaxcyte |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $10.9Bhigher | $9.4Blower |
| Revenue | $5.1B | — |
| Earnings | $344Mhigher | -$766.6Mlower |
| Employees | 46,000higher | 507lower |
| Total assets | $5.5Bhigher | $3Blower |
| Valuation | ||
| P/E | 27.7 | — |
| P/S | 2.1 | — |
| P/B | 4.2higher | 3.6lower |
| Dividend yield | 0.14%higher | 0.00%lower |
| Profitability | ||
| Operating margin | 8.41% | — |
| Balance sheet | ||
| Net assets | $2.2Blower | $2.7Bhigher |
| Total liabilities | $3.2Bhigher | $317.2Mlower |
| Total debt | $144.4M | — |
| Cash on hand | $503.9Mhigher | $174Mlower |
| Price change | ||
| Today | -1.17%higher | -3.59%lower |
| 1 year | +5.45%lower | +24.4%higher |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (0)
None of the tracked investors.
Ensign Group only (1)
Vaxcyte only (2)
- Peter Kolchinsky5.8%
- Lee Ainslie0.8%
Percentages are each holding's share of that investor's reported portfolio. Who owns ENSG · Who owns PCVX
More on Ensign Group
Further comparisons
Ensign Group against its closest peers
Vaxcyte against its closest peers
Learn
Questions and answers
Which is bigger, Ensign Group or Vaxcyte?
By market value, Ensign Group is the larger: $10.9B against $9.4B for Vaxcyte.
Which has the higher dividend yield?
Ensign Group: 0.14%, against 0.00% for Vaxcyte. Dividend yield is the last twelve months' dividends as a share of today's share price.
Which superinvestors own both Ensign Group and Vaxcyte?
None of the tracked superinvestors holds both in their latest 13F filing. 1 holds Ensign Group and 2 hold Vaxcyte.
Cite this page
Funkfolio, “Ensign Group vs Vaxcyte”, data as of 18 November 2026. https://funkfolio.com/compare/ensg-vs-pcvx
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.